GO curators for mouse genes have assigned the following annotations to the gene product of Acvr2a. (This text reflects annotations as of Wednesday, January 23, 2013.) MGI curation of this mouse gene is considered complete, including annotations derived from the biomedical literature as of March 6, 2008. If you know of any additional information regarding this mouse gene please let us know. Please supply mouse gene symbol and a PubMed ID.Summary from NCBI RefSeq
[Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. [provided by RefSeq, Jul 2008]Summary text based on GO annotations supported by experimental evidence in mouse
Researchers have inferred from direct assay, that the gene product of Acvr2a
participates in the following biological processes:
Andersson O et al. (2007) Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development. Dev Biol, 311:500-11. (PubMed:17936261)
De Winter JP et al. (1996) Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors. Exp Cell Res, 224:323-34. (PubMed:8612709)
Kumar TR et al. (2001) Male reproductive phenotypes in double mutant mice lacking both FSHbeta and activin receptor IIA. Endocrinology, 142:3512-8. (PubMed:11459797)
Lee SJ et al. (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A, 98:9306-11. (PubMed:11459935)
Lee YJ et al. (2006) Generation of activin receptor type IIB isoform-specific hypomorphic alleles. Genesis, 44:487-94. (PubMed:16991118)
Liu ZH et al. (2006) Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling. J Endocrinol, 189:409-21. (PubMed:16648306)
Ma X et al. (2005) Impaired male sexual behavior in activin receptor type II knockout mice. Biol Reprod, 73:1182-90. (PubMed:16093358)
Mathews LS et al. (1991) Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell, 65:973-82. (PubMed:1646080)
Matzuk MM et al. (1995) Different phenotypes for mice deficient in either activins or activin receptor type II [see comments] Nature, 374:356-60. (PubMed:7885474)
Oh SP et al. (2002) Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev, 16:2749-54. (PubMed:12414726)
Song J et al. (1999) The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. Dev Biol, 213:157-69. (PubMed:10452853)
Wreford NG et al. (2001) Analysis of the testicular phenotype of the follicle-stimulating hormone beta-subunit knockout and the activin type II receptor knockout mice by stereological analysis. Endocrinology, 142:2916-20. (PubMed:11416011)
Xia Y et al. (2007) Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. J Biol Chem, 282:18129-40. (PubMed:17472960)
Xu J et al. (1995) Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem, 270:6308-13. (PubMed:7890768)